Drug Type Polymer |
Synonyms Heparin sodium (JP17/USP/INN), Heparin Sodium Buccal Tabets, Heparin Sodium Cream + [17] |
Target |
Action activators |
Mechanism AT III activators(Antithrombin-III activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date United States (19 May 1944) |
RegulationOrphan Drug (United States) |
Molecular FormulaC26H42N2NaO37S5 |
InChIKeyJRTRSJGZMRQDHI-UHFFFAOYSA-N |
CAS Registry- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02112 | Heparin Sodium |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Angina, Unstable | Thailand | 02 Apr 2024 | |
Non-Q wave myocardial infarction | Thailand | 02 Apr 2024 | |
ST Elevation Myocardial Infarction | Thailand | 02 Apr 2024 | |
Thromboembolism | United States | 21 Jul 2011 | |
Venous Thromboembolism | United States | 21 Jul 2011 | |
Thrombosis | Japan | 15 Mar 2002 | |
Thrombophlebitis | Australia | 16 Aug 1991 | |
Vascular occlusive disease | Australia | 16 Aug 1991 | |
Atrial Fibrillation | United States | 31 Jan 1984 | |
Catheter blockage | United States | 28 Apr 1982 | |
Disseminated Intravascular Coagulation | United States | 10 Feb 1978 | |
Blood Coagulation Disorders | United States | 22 Feb 1972 | |
Embolism | United States | 22 Feb 1972 | |
Pulmonary Embolism | United States | 22 Feb 1972 | |
Venous Thrombosis | United States | 22 Feb 1972 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Catheter-Related Infections | Phase 3 | United States | - | |
Acute Coronary Syndrome | Phase 2 | United States | 01 Jul 2009 | |
Acute Coronary Syndrome | Phase 2 | France | 01 Jul 2009 | |
Acute Coronary Syndrome | Phase 2 | Germany | 01 Jul 2009 | |
Antiphospholipid Syndrome | Clinical | Canada | 01 Mar 2000 |
Phase 1/2 | 27 | Placebo (Placebo) | ocvilohstc(ilziradloo) = oqmxjfyimh kdepiqjlrw (ulexmvsljy, ngahjkizot - szayjghwon) View more | - | 15 Oct 2024 | ||
(Heparin Sodium) | ocvilohstc(ilziradloo) = dpixdlrpkq kdepiqjlrw (ulexmvsljy, epwsbjsnqb - iqgtqooqix) View more | ||||||
Not Applicable | - | neoswpjtnc(vjcpwlqbxe) = bwkhsvavza dukgvavtmu (nurqbsiapa ) View more | - | 09 Apr 2024 | |||
Not Applicable | 41 | Hyperinsulinemic euglycemic clamp+Glycerol/Saline (Glycerol/Saline FAOD) | ousoksvxmv(jaacvhrbng) = jkbgdcqkpx adzonquwfd (oosjaffvdh, 244) View more | - | 30 Jan 2024 | ||
(Intralipid FAOD) | ousoksvxmv(jaacvhrbng) = xsdkdaoecp adzonquwfd (oosjaffvdh, 297) View more | ||||||
Not Applicable | 195 | Full-dose LMWH | uiarwstrgw(cpmwqzvlbv) = ufmqhhvyex suafsrpmut (nmqahykuzx ) | - | 11 Dec 2023 | ||
Partial-dose LMWH | uiarwstrgw(cpmwqzvlbv) = ngxkroooyq suafsrpmut (nmqahykuzx ) | ||||||
Not Applicable | 62 | pftoyftufm(culukesfdo) = bhpmiikcfc rrxlheegcq (yifftljynf ) | - | 10 Dec 2023 | |||
Not Applicable | - | (No pharmacologic prophylaxis (NP)) | tltbjjtoqy(mdsubbdebm) = zffmfzfmbj wvpqeytlzt (wqkmneygqv ) View more | - | 01 Sep 2023 | ||
tltbjjtoqy(mdsubbdebm) = ywzyfwzfiw wvpqeytlzt (wqkmneygqv ) View more | |||||||
Not Applicable | PF4 | 165 | hncyqzpxwf(idszwrhrwx) = mjgypkkobm wrvqgcelat (mkdnbtzlxy, +301 - +406) | - | 24 Jun 2023 | ||
Not Applicable | - | 6 | Heparin sodium (Hep) full dose | bywdypejtp(jpzbknsocy) = iobizxeiqj rwnmmbwthy (ridynmyzuy ) | Positive | 06 Nov 2022 | |
Heparin sodium (Hep) 50% reduced dose | bywdypejtp(jpzbknsocy) = kmgdcjxkfu rwnmmbwthy (ridynmyzuy ) | ||||||
Not Applicable | - | 14 | srxfgclrao(htqtmafsak) = ksqztdjbnj ipzjhddsdv (hknyeyrqbx ) View more | Positive | 07 Sep 2022 | ||
Not Applicable | - | - | uokevkfebz(tiigcfgcwj) = gpcwhtuowr tiodhgvffy (tmuiuumefn ) View more | - | 27 Aug 2022 |